Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: A randomized, controlled study

British Journal of Anaesthesia

Volumn 115, Issue 5, 2015, Pages 743-751

  Brueckmann, B ^a   Sasaki, N ^a   Grobara, P ^b   Li, M K ^c   Woo, T ^c   De Bie, J ^c   Maktabi, M ^a   Lee, J ^a   Kwo, J ^a,d   Pino, R ^a,d   Sabouri, A S ^a   Mcgovern, F ^a,d   Staehr Rye, A K ^a,e   Eikermann, M ^a,d,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MSD   (Netherlands)

^c MERCK RESEARCH LABORATORIES   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

neostigmine glycopyrrolate; neuromuscular blockade; neuromuscular blocking agents; randomized controlled trial; rocuronium; sugammadex

Indexed keywords

GLYCOPYRRONIUM BROMIDE; NEOSTIGMINE; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; DRUG COMBINATION; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ABDOMINAL SURGERY; ACUTE HEART INFARCTION; ADULT; AIRWAY OBSTRUCTION; APNEA; ARTICLE; BACKACHE; BLEEDING; BRADYCARDIA; CLINICAL DECISION MAKING; CONTROLLED STUDY; COUGHING; CRACKLE; DELIRIUM; DIARRHEA; DRUG FEVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOVENTILATION; ILEUS; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NAUSEA; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; OPERATING ROOM; PARALYTIC ILEUS; PARESIS; PHARYNX DISEASE; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SINGLE BLIND PROCEDURE; TACHYCARDIA; URINE RETENTION; VOMITING; WOUND INFECTION; ABDOMEN; AGED; ANESTHETIC RECOVERY; ANTAGONISTS AND INHIBITORS; DELAYED EMERGENCE FROM ANESTHESIA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECTS; GENERAL ANESTHESIA; MIDDLE AGED; NEUROMUSCULAR SYNAPSE; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PROCEDURES; SURGERY;

ABDOMEN; ADULT; AGED; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; DELAYED EMERGENCE FROM ANESTHESIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GAMMA-CYCLODEXTRINS; GLYCOPYRROLATE; HUMANS; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE CARE;

EID: 84946108849     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev104     Document Type: Article

References (35)

1. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr. Hospital costs associatedwith surgical complications: a report fromthe private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004; 199: 531-7
2. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-Term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005; 242: 326-41; discussion 41-3
3. Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006; 144: 581-95
4. Nafiu OO, Ramachandran SK, Ackwerh R, Tremper KK, Campbell DA Jr, Stanley JC. Factors associated with and consequences of unplanned post-operative intubation in elderly vascular and general surgery patients. Eur J Anaesthesiol. 2011; 28: 220-4
5. Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. Br Med J. 2012; 345: e6329
6. Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-Acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010; 105: 304-9
7. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-Acting neuromuscular blocking drugs. Anaesthesia. 2001; 56: 312-8
8. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997; 41: 1095-103
9. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008; 107: 130-7
10. Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T. The influence of residual neuromuscular block on the incidence of critical respiratory events A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol. 2011; 28: 842-8
11. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007; 51: 789-808
12. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008; 109: 816-24
13. Booij LH, de Boer HD, van Egmond J. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Semin Anesth Periop Med. 2002; 21: 92-8
14. Saarnivaara L, Simola M. Effects of four anticholinesteraseanticholinergic combinations and tracheal extubation on QTc interval of the ECG, heart rate and arterial pressure. Acta Anaesthesiol Scand. 1998; 42: 460-3
15. Meyer M, Bateman B, Kurth T, Eikermann M. Neostigmine reversal does not appear to improve postoperative respiratory safety. Br Med J. 2013; 346: f1460
16. Sasaki N, Meyer MJ, Malviya SA, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology. 2014; 121: 959-68
17. Bom A, BradleyM, Cameron K, et al A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002; 41: 266-70
18. Geldner G, Niskanen M, Laurila P, et al A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Anaesthesia. 2012; 67: 991-8
19. Lemmens HJ, El-Orbany MI, Berry J, Morte JB Jr, Martin G. Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine. BMC Anesthesiol. 2010; 10: 15
20. Puhringer FK, Rex C, Sielenkamper AW, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. 2008; 109: 188-97
21. Kopman AF, Yee PS, Neuman GG. Relationship of the trainof-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997; 86: 765-71
22. Thomas DG. Algorithm AS-36. Exact Confidence Limits for the Odds Ratio in a 2 2 Table. Appl Stat. 1971; 20: 105-10
23. Sabo D, Jones RK, Berry J, et al. Residual Neuromuscular Blockade at Extubation, A Randomized Comparison of Sugammadex and Neostigmine Reversal of Rocuronium-Induced Blockade in Patients Undergoing Abdominal Surgery. J Anesthe Clinic Res. 2011; 2: 140
24. Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth. 2010; 105: 558-67
25. Young WL, Matteo RS, Ornstein E. Duration of action of neostigmine and pyridostigmine in the elderly. Anesth Analg. 1988; 67: 775-8
26. Maybauer DM, Geldner G, Blobner M, et al. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia. 2007; 62: 12-7
27. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003; 98: 1042-8
28. Mirzakhani H, Williams JN, Mello J, et al. Muscle weakness predicts pharyngeal dysfunction and symptomatic aspiration in long-Term ventilated patients. Anesthesiology. 2013; 119: 389-97
29. Eikermann M, Zaremba S, Malhotra A, Jordan AS, Rosow C, Chamberlin NL. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing. Br J Anaesth. 2008; 101: 344-9
30. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol. 2010; 27: 874-81
31. Brueckmann B, Villa-Uribe JL, Bateman BT, et al. Development and Validation of a Score for Prediction of Postoperative Respiratory Complications. Anesthesiology. 2013; 118: 1276-85
32. Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013; 117: 345-51
33. Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anaesth. 2011; 58: 944-7
34. Baillard C, Bourdiau S, Le Toumelin P, et al. Assessing residual neuromuscular blockade using acceleromyography can be deceptive in postoperative awake patients. Anesth Analg. 2004; 98: 854-7
35. Brull SJ, Ehrenwerth J, Connelly NR, Silverman DG. Assessment of residual curarization using low-current stimulation. Can J Anaesth. 1991; 38: 164-8